Language: 简体中文 English
您现在的位置: 首页 > 摘要投稿


Early bird registration will be offered to all accepted abstracts till 2 weeks after acceptance notification!
Limited number of scholarships (FREE REGISTRATIONS) will be available for accepted abstracts from LMICs !

Deadline: Tuesday, March 1, 2022 – 23:59 – Beijing Time


Abstract Submission Opens Saturday, January 1, 2022
Abstract Submission Deadline Tuesday, March 1, 2022 
Abstract Notification Second week of March, 2022

*Note all efforts are made to send notifications by the planned date. Should there be any delays with the selection process, revised dates will be posted here

Rules for Submission

Please read the submission rules before submitting an abstract.

· Abstracts must be submitted online via the website only.

· Presentation Type: Abstracts may be submitted for oral or Poster.

· Abstracts must be received by the announced deadline.


· Prospective multicenter trials as well as presentation of large translational works are considered as major quality criteria. Inter-diseases sessions (such as target, pathway or immunology oriented) will be planned.

· Clinical Trials in Progress Abstracts cannot be submitted

· Previous Publications of an Abstract – an abstract cannot be submitted if it was presented in 2021 or earlier, unless there is significant new data.

· The same person may submit up to 5 abstracts regardless of presenting author.

· The same person may serve as presenting author on up to 3 abstracts.

· Presenting authors must be registered participants. Only abstracts of authors who have paid their registration fees by the date indicated in the notification email will be scheduled for presentation.

· The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract.

· Abstracts must be submitted in English.

· Instructions for preparation of presentations will be made available on the congress website.



Before you begin, please prepare the following information:

· Presenting author’s contact details:
– Full first and family name(s)
– Email address
– Affiliation details: department, institution / hospital, city state (if relevant), Country

· Author and co-authors’ details

· Preferred Presentation type: Oral Presentation/Poster

· Abstract title – must be in UPPER CASE and limited to 25 words. Please submit symbols as words.

· Abstract text – limited to 300 words including acknowledgements.

· Abstract topic– select the abstract topic per the

· Text only is to be submitted. Tables, figures and bulleted text are not permitted.

· Abstracts should clearly state:
Background and aims

· Use only standard abbreviations. Abbreviations must be consistent with instructions to authors of the Pediatric Blood & Cancer Journal and be defined on 1st usage, then use of abbreviation alone is OK. Please use as few abbreviations as possible and only commonly used abbreviations.

· Disease names should be written without apostrophes, for example: Wilms tumour, Burkitt lymphoma, Hodgkin disease, etc. Please do not refer to patients by their diseases, e.g. ‘Wilms tumour patients’. Instead identify them as ‘patients with Wilms tumour’.

· Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content.

· Submissions may not contain patient names, hospital ID numbers or other identifying information.

· Numbers over 999 must include a comma, e.g., 2,000.

· Numbers beginning with a decimal point should be preceded by a zero.

· Periods should be used in numbers for decimal points, not commas, i.e. P=0.015

· All measurements must be in metric units.

· Do not begin sentences with a number – type the number in full, for example, it should be ‘Three patients….’ Instead of ‘3 patients….’.

· Abstracts stating “data will be discussed in the presentation” will NOT be accepted.

· Click on the SUBMIT button at the end of the process in order to save your abstract. You may log in to the system later to make changes to your abstract, up to the submission deadline. After the deadline, changes will not be possible.

· You will receive an abstract reference number via email after you have submitted your abstract. Please refer to this abstract number in all correspondence regarding the abstract.

· Please if you have not received confirmation that your abstract has been submitted.

· Please do not submit multiple copies of the same abstract.


All abstracts will be evaluated anonymously and scored by the appropriate SIOP ASIA Scientific Committee members. The Scientific Committee will determine whether the abstract will be accepted for presentation, with consideration given to the author’s preference.
The Scientific Committee will determine If accepted as:

· an oral presentation

· a poster presentation, possibly with a poster session participation or special Scientific Committee mention